Ondine Biomedical Inc. (OBI.L)
GBp 8.13
(4.84%)
GBp 8.13
(4.84%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.2 Million CAD | 88.56% |
| 2022 | 638 Thousand CAD | -75.17% |
| 2021 | 2.56 Million CAD | 43.44% |
| 2020 | 1.79 Million CAD | 285.99% |
| 2019 | 464 Thousand CAD | 24.4% |
| 2018 | 373 Thousand CAD | -9.47% |
| 2017 | 412 Thousand CAD | 0.0% |
| 2010 | 1.53 Million CAD | 48.79% |
| 2009 | 1.03 Million CAD | 12.92% |
| 2008 | 912.32 Thousand CAD | -43.17% |
| 2007 | 1.6 Million CAD | -0.85% |
| 2006 | 1.61 Million CAD | 0.0% |
| 2005 | - CAD | 0.0% |
| 2003 | - CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 499.9 Thousand GBP | 0.0% |
| 2023 Q2 | 257.5 Thousand GBP | 0.0% |
| 2023 Q4 | 457.62 Thousand GBP | 0.0% |
| 2023 FY | 1.2 Million CAD | 88.56% |
| 2022 FY | 638 Thousand CAD | -75.17% |
| 2022 Q2 | 158.93 Thousand GBP | 0.0% |
| 2022 Q4 | 240.47 Thousand GBP | 0.0% |
| 2021 FY | 2.56 Million CAD | 43.44% |
| 2020 FY | 1.79 Million CAD | 285.99% |
| 2019 FY | 464 Thousand CAD | 24.4% |
| 2018 FY | 373 Thousand CAD | -9.47% |
| 2017 FY | 412 Thousand CAD | 0.0% |
| 2011 Q1 | 400.97 Thousand CAD | -27.58% |
| 2011 Q2 | 640.04 Thousand CAD | 59.62% |
| 2010 Q2 | 207.98 Thousand CAD | -26.94% |
| 2010 FY | 1.53 Million CAD | 48.79% |
| 2010 Q1 | 284.68 Thousand CAD | 4.49% |
| 2010 Q4 | 553.67 Thousand CAD | 31.12% |
| 2010 Q3 | 422.25 Thousand CAD | 103.02% |
| 2009 Q4 | 272.44 Thousand CAD | 42.01% |
| 2009 FY | 1.03 Million CAD | 12.92% |
| 2009 Q1 | 194.18 Thousand CAD | -35.7% |
| 2009 Q2 | 371.75 Thousand CAD | 91.45% |
| 2009 Q3 | 191.84 Thousand CAD | -48.39% |
| 2008 Q1 | 202.02 Thousand CAD | 57.19% |
| 2008 FY | 912.32 Thousand CAD | -43.17% |
| 2008 Q3 | 147.92 Thousand CAD | -43.19% |
| 2008 Q4 | 301.98 Thousand CAD | 104.15% |
| 2008 Q2 | 260.38 Thousand CAD | 28.89% |
| 2007 Q3 | 358.82 Thousand CAD | -29.72% |
| 2007 FY | 1.6 Million CAD | -0.85% |
| 2007 Q4 | 128.52 Thousand CAD | -64.18% |
| 2007 Q1 | 607.55 Thousand CAD | -7.77% |
| 2007 Q2 | 510.57 Thousand CAD | -15.96% |
| 2006 Q3 | 536.08 Thousand CAD | 26.32% |
| 2006 FY | 1.61 Million CAD | 0.0% |
| 2006 Q4 | 658.72 Thousand CAD | 22.88% |
| 2006 Q2 | 424.39 Thousand CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| 2005 Q1 | - CAD | 0.0% |
| 2005 Q2 | - CAD | 0.0% |
| 2005 Q3 | - CAD | 0.0% |
| 2005 Q4 | - CAD | 0.0% |
| 2004 Q3 | - CAD | 0.0% |
| 2004 Q4 | - CAD | 0.0% |
| 2004 Q2 | - CAD | 0.0% |
| 2004 Q1 | - CAD | 0.0% |
| 2003 FY | - CAD | 0.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2003 Q4 | - CAD | 0.0% |
| 2003 Q3 | - CAD | 0.0% |
| 2003 Q2 | - CAD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| 2001 Q4 | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|